1. Home
  2. INVE vs QNCX Comparison

INVE vs QNCX Comparison

Compare INVE & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Identiv Inc.

INVE

Identiv Inc.

HOLD

Current Price

$4.84

Market Cap

119.1M

Sector

Technology

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$1.21

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INVE
QNCX
Founded
1990
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
119.1M
19.9M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
INVE
QNCX
Price
$4.84
$1.21
Analyst Decision
Strong Buy
Hold
Analyst Count
2
2
Target Price
$5.50
N/A
AVG Volume (30 Days)
332.7K
1.4M
Earning Date
05-13-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
$60,219,000.00
N/A
Revenue This Year
$22.10
N/A
Revenue Next Year
$20.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.21
N/A
52 Week Low
$3.08
$0.08
52 Week High
$5.30
$4.55

Technical Indicators

Market Signals
Indicator
INVE
QNCX
Relative Strength Index (RSI) 62.63 59.82
Support Level $3.25 $1.17
Resistance Level N/A $1.50
Average True Range (ATR) 0.31 0.09
MACD 0.01 -0.04
Stochastic Oscillator 73.33 12.50

Price Performance

Historical Comparison
INVE
QNCX

About INVE Identiv Inc.

Identiv Inc develops specialty radio-frequency identification (RFID) and Internet of Things It (IoT) solutions that address customers' challenges and create new opportunities for them through the digitization and enhanced connectivity to the IoT. It designs, produces, and sells RFID and Bluetooth Low Energy (BLE) enabled devices, RFID inlays, tags, and labels that can be applied or incorporated into physical objects, providing them with a digital identity and the ability for customers to track, monitor, authenticate, and engage with consumers. Its IoT Business segment develops, manufactures, and supplies specialty IoT solutions tailored for the healthcare, logistics, smart packaging industries and other high-value end markets.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Share on Social Networks: